SCHEMBL6358459

SCHEMBL6358459

COCCc1cccc(C)c1C=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 3/20 0.34
TSHR P16473 2/20 0.34
ALOX5 P09917 1/20 0.33
TRIM24 O15164 1/20 0.33
TRIM33 Q9UPN9 1/20 0.33
SCN8A Q9UQD0 1/20 0.33
PTPN1 P18031 1/20 0.33
TAAR1 Q96RJ0 1/20 0.32
CDK4 P11802 2/20 0.32
CCND1 P24385 2/20 0.32
POLB P06746 1/20 0.32
HPGD P15428 1/20 0.32
CCNB2 O95067 1/20 0.32
CDK1 P06493 1/20 0.32
CCNB1 P14635 1/20 0.32
CCNB3 Q8WWL7 1/20 0.32
ADRA1A P35348 2/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6353982 0.82 IGF1R (0.39) KDM4EALDH1A1TSHRTRIM24TRIM33
SCHEMBL6215661 0.79 PTGER4 (0.41) ALDH1A1TSHRADRA1ATDP1HTR1A
SCHEMBL606253 0.77 GABRA1 (0.43) ALDH1A1TSHRTRIM24TRIM33TAAR1
SCHEMBL28632291 0.77 GAA (0.39) KDM4ETSHRALOX5TDP1
SCHEMBL8816288 0.75 TAAR1 (0.56) KDM4EALDH1A1TSHRALOX5TAAR1
SCHEMBL7745169 0.75 BID (0.45) KDM4E
SCHEMBL25588405 0.74 ABCB1 (0.52) TAAR1HTR1A
SCHEMBL605657 0.74 ALDH1A1 (0.43) KDM4EALDH1A1TSHRTRIM24TRIM33
SCHEMBL1200782 0.73 ALDH1A1 (0.47) ALDH1A1TSHRTRIM24TRIM33HPGD
SCHEMBL6355829 0.73 GABRA1 (0.39) KDM4EALDH1A1TSHRALOX5SCN8A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050154007-A1 New compounds AMIN KOSRAT (SE) 2005-07-14 US disclosed
US-6790960-B2 Compounds ASTRAZENECA AB (SE) 2004-09-14 US disclosed
US-20030220364-A1 New compounds AMIN KOSRAT (SE) 2003-11-27 US disclosed
US-6579884-B1 Compounds ASTRAZENECA AB (SE) 2003-06-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030220364-A1 New compounds SLC10A2, GIPR, FABP2 KDM4E 4741/4885ALDH1A1 1399/4885TSHR 2682/4885
US-20050154007-A1 New compounds SLC10A2, GIPR, FABP6 KDM4E 4725/4885ALDH1A1 1838/4885TSHR 2629/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.